X. Jin et al. / Tetrahedron 60 (2004) 2881–2888
2887
2
5
the solvent under reduced pressure using a rotavapor the
residue was column chromatographed on silica gel (20 g)
with AcOEt–PE (1:5) giving a pale yellow oil (150 mg,
401.3411 (C H O þH requires 401.3420); [a] ¼þ134
2
7
44
2
D
(c 0.3 in acetone); l
Table 1.
(MeOH, nm) 206. For NMR data see
max
7
5
5%) of isotachysterol (all-trans-9,10-secocholesta-
(10),6,8(14)-trien-3b-ol (5): HR-ESI-MS: 385.3463
4.3.6. 3,10-epoxy-5-oxo-5,10-seco-9,10-secocholesta-
6,8(14)-dien-10-ol (10). HR-ESI-MS (417.3378 for
2
5
(
C H OþH requires 385.3470); [a] ¼þ4 (c 0.3 in
(neat, cm ) 3403 (OH), 1671 and 1589
max
2
7
44
D
2
1
acetone); n
C H O þH, requires 417.3369); l (MeOH, nm) 305.
max
27 44
3
(
conjugated triene), 957 (trans-CHv); lmax (MeOH, nm)
For NMR data see Table 1.
288, indicative of an all-trans-triene system. For NMR data
see Table 1.
Acknowledgements
4
.2. Autoxidation of isotachysterol (5)
We thank the National Natural Science Foundation of China
Grant Nos. 20172025 and 20332020) for financial support.
We also thank the referee who suggested the alternative
mechanism as supplemented in Scheme 2.
The pale yellow oil of 5 (150 mg) was laid in a small beaker
at ambient temperature in the dark which was oxidized
rapidly to a very complex mixture as monitored by TLC,
and after 1–2 days little 5 was left. Oxidation by bubbling
air to a benzene solution of 5 at 40 8C for 4 h gave the same
result. The reaction mixture was separated by column
chromatography (silica gel, AcOEt–PE, 1:1 v/v) followed
by HPLC to give 6a (10.6 mg), 6b (6.3 mg), 7a (4.0 mg), 7b
(
References and notes
(
5.8 mg), 8 (8.0 mg) and 10 (3.2 mg) respectively. Com-
1. (a) In Vitamin D; Feldman, D., Glorieux, F. H., Pike, J. W.,
Eds.; Academic: San Diego, 1997. (b) In Vitamin D: basic
clinical aspects; Kumar, R., Ed.; Martinus Nijhoff: Boston,
pound 9 could not be collected because it was unstable and
changed to 10 during HPLC separation.
1
984. (c) Norman, A. W. Vitamin D: the calcium homeostatic
4
.3. Stereospecific epoxidation of isotachysterol (5)
steroid hormone; Academic: London, 1979. (d) Havinga, E.
Experientia 1973, 15, 1181–1193.
To a solution of 5 (100 mg, 0.31 mmol) and VO(acac)2
2 mg, 7.3 mmol) in dry benzene (2 ml) was added slowly
2. (a) Horst, R. L.; Reinhardt, T. A. In Vitamin D; Feldman, D.,
Glorieux, F. H., Pike, J. W., Eds.; Academic: San Diego, 1997;
pp 13–31. (b) Reichel, H.; Koeffler, H. R.; Norman, A. W.
New Engl. J. Med. 1989, 320, 980–991. (c) Reischl, W.;
Zbiral, E. Liebigs Ann. Chem. 1985, 1210–1215.
(
anhydrous benzene solution of TBHP (0.21 ml, 0.62 mmol)
at 5 8C. The solution was then stirred for 30 min at 5 8C.
After addition of aqueous Na SO , the mixture was
2
3
extracted with benzene, the extracts were washed with
brine, dried over Na SO , and evaporated. The residue was
3. (a) Tian, W.-S.; He, L.-W.; Wang, C. In Progress in steroid
chemistry; Zhou, W.-S., Zhuang, Z.-P., Eds.; Science: Beijing,
2002; pp 204–230. (b) Colston, K. W.; Mackay, A. G.; James,
S. Y.; Binderup, L.; Chander, S.; Coombes, R. C. Biochem.
Pharmacol. 1992, 44, 2273–2280. (c) Yeung, B.; Vouros, P.
Mass Spectrosc. Rev. 1995, 14, 179–194. (d) Fujishima, T.;
Konno, K.; Nakagawa, K.; Kurobe, M.; Okano, T.; Takayama,
H. Bioorg. Med. Chem. 2000, 8, 123–134.
2
4
chromatographed (silica gel, AcOEt–PE 1:1) to give 6a
43 mg, 43%) as the predominant product.
(
4
3
4
.3.1. (5R)-5,10-epoxy-9,10-secocholesta-6,8(14)-dien-
b-ol [5b,10-epoxy-isotac-hysterol] (6a). HR-ESI-MS:
2
5
01.3413 (C H O þH requires 401.3420; [a] ¼þ25.8
2
7
44
2
D
2
1
(c 1.0 in acetone); n
and 800 (epoxide), 971 (trans-CHv); lmax (MeOH, nm)
(neat, cm ) 3386 (OH), 1278, 859
4. DeLuca, H. F.; Schnoes, H. K.; Tanaka, Y. US Patent 4,229,
395, 1980..
5. Nakayama, K.; Yamada, S.; Takayama, H. J. Org. Chem.
max
2
47. For NMR data see Table 1.
1
984, 49, 1537–1539.
4
3
4
.3.2. (5S)-5,10-epoxy-9,10-secocholesta-6,8(14)-dien-
b-ol [5a,10-epoxy-isotac-hysterol] (6b). HR-ESI-MS:
6. (a) King, J. M.; Min, D. B. J. Food Sci. 1998, 63, 31–34.
(b) Yamada, S.; Nakayama, K.; Takayama, H.; Itai, A.; Iitaka,
Y. J. Org. Chem. 1983, 48, 3477–3483.
2
5
01.3422 (C H O þH requires 401.3420); [a] ¼þ29.1
2
7
44
2
D
2
1
(
c 1.0 in acetone); n
(neat, cm ) 3388 (OH), 1275, 874
and 836 (epoxide), 970 (trans-CHv); lmax (MeOH, nm)
7. Verloop, A.; Koevoet, A. L.; Moorselaar, V. T.; Havinga, E.
Recueil 1959, 78, 1004–1016.
8. Agarwal, V. L. J. Steroid Biochem. 1990, 35, 149–150.
max
2
47. For NMR data see Table 1.
9
. Mizhiriskii, M. D.; Konstantinovskii, L. E.; Vishkautsan, R.
Tetrahedron 1996, 52, 1239–1252.
4
.3.3. (10R)-9,10-secocholesta-5,7,14-triene-3b,10-diol
(
7a). HR-ESI-MS: 401.3416 (C H O þH requires
10. Boomsma, F.; Jacobs, H. J. C.; Havingga, E.; Gen, A. V. D.
J. Royal Netherlands Chem. Soc. 1977, 96, 104–109.
11. (a) Sharpless, K. B.; Michaelson, R. C. J. Am. Chem. Soc.
2
7 44 2
2
5
4
nm) 278. For NMR data see Table 1.
01.3420); [a] ¼2144 (c 0.7 in acetone); l
(MeOH,
D
max
1
973, 95, 6136–6137. (b) Sharpless, K. B.; Verhoeven, T. R.
4
.3.4. (10S)-9,10-secocholesta-5,7,14-triene-3b,10-ol
Aldrichim. Acta 1979, 12, 63–73. (c) Mihelich, E. D.
Tetrahedron Lett. 1979, 20, 4729–4732. (d) Mihelich, E. D.;
Daniels, K. J. Am. Chem. Soc. 1981, 103, 7690–7692.
(
7b). HR-ESI-MS: 401.3411 (C H O þH requires
2
7 44 2
2
5
4
nm) 278. For NMR data see Table 1.
01.3420); [a] ¼2112 (c 0.6 in acetone); l
(MeOH,
D
max
12. Okamurr, W. H.; Hammond, M. L.; Anthony, A. R.; Norman,
W.; Wing, R. M. J. Org. Chem. 1977, 42, 2284–2291.
4.3.5. (7R,10R)-7,10-epoxy-9,10-secocholesta-5,8(14)-
dien-3b-ol [7,10-epoxy-isotac-hysterol] (8). HR-ESI-MS:
13. Mordi, R. C.; Walton, J. C. Tetrahedron 1993, 49, 911–928.
14. (a) Doering, W. von E.; Kitagawa, T. J. Am. Chem. Soc. 1991,